Raiffeisen Bank International AG / Key word(s): Half Year Results 21.08.2014 07:36 Dissemination of an Ad hoc announcement, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- - Net interest income of EUR 1,954 mn (up 6.4% y-o-y) - Net trading income of EUR 9 mn (down 93.6% y-o-y), impacted by currency-driven valuation losses in Ukraine - General administrative expenses decreased to EUR 1,519 mn (down 6.1% y-o-y), primarily driven by FX effects - Net provisioning for impairment losses increased to EUR 568 mn (up 21.1% y-o-y) - Profit before tax increased to EUR 518 mn (up 10.9% y-o-y) - Consolidated profit increased to EUR 344 mn (up 24.4% y-o-y) - NPL ratio at 10.7% (stable compared to FY 2013) - NPL coverage ratio increased to 65.3% (up 2.2PP compared to FY 2013) - Common equity tier 1 ratio: CET1 (fully loaded) 10.4%; CET1 (transitional) 12.1% - Leverage ratio of 6.3% comfortably surpasses the 3% envisaged regulatory ratio Income Statement in EUR mn 1-6/2014 1-6/2013 Q2/2014 Q1/2014 Net interest income 1,954 1,836 975 979 Net provisioning for impairment losses (568) (469) (287) (281) Net interest income after provisioning 1,386 1,367 688 697 Net fee and commission income 765 785 389 376 Net trading income 9 140 28 (19) General administrative expenses (1,519) (1,617) (764) (755) Net income from derivatives and liabilities (43) (187) (15) (27) Net income from financial investments 78 64 42 37 Profit before tax 518 467 278 240 Profit after tax 371 311 198 173 Consolidated profit 344 277 183 161 Balance Sheet in EUR mn 30/6/14 31/12/13 Equity 10,846 10,364 Total assets 127,279 130,640 NPL ratio 10.7% 10.7% NPL coverage ratio 65.3% 63.1% Bank Specific Information 30/6/14 31/12/13 Common equity tier 1 ratio (transitional) 12.1% 10.7% Common equity tier 1 ratio (fully loaded) 10.4% n/a Performance 1-6/2014 1-6/2013 Net interest margin 3.33% 3.06% Return on equity before tax 8.6% 8.6% Consolidated return on equity 5.4% 4.6% Cost/income ratio 55.3% 57.5% Earnings per share in EUR 0.88 0.91 Resources 30/6/14 31/12/13 Employees 56,356 57,901 Business outlets 2,934 3,025 For further information please contact: Susanne E. Langer Head of Group Investor Relations Spokesperson Raiffeisen Bank International AG Am Stadtpark 9 1030 Vienna, Austria ir@rbinternational.com phone +43-1-71 707-2089 www.rbinternational.com 21.08.2014 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Raiffeisen Bank International AG Am Stadtpark 9 A-1030 Vienna Austria Phone: +43-1-71707-2089 Fax: +43-1-71707-2138 E-mail: ir@rbinternational.com Internet: www.rbinternational.com ISIN: AT0000606306 WKN: A0D9SU Listed: Wien (Amtlicher Handel / Official Market) End of Announcement DGAP News-Service ---------------------------------------------------------------------------
DGAP-Adhoc: Raiffeisen Bank International AG: Semi-Annual
Top 10 Most Recent News Articles
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data
Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...
Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations
ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...
Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms
Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...
Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control
Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...
Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined
Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...
Continue Reading
Uber Data Breach: Class Action Investigation Begins
When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...
Continue Reading
D-Wave Quantum Hit with Securities Fraud Lawsuit
A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...
Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup
An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....
Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly
Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...
Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries
JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...
Continue ReadingTop 5 Most Recently Viewed Articles
Leadership Transition at Ignitis Renewables Sparks Future Growth
Leadership Transition at Ignitis Renewables AB “Ignitis grup?” has announced a significant change in leadership with the resignation of Thierry Aelens, the Chief Executive Officer (CEO) of its subsidiary, UAB “Ignitis Renewables.” Aelens will step down effective at the end of March 2025 for personal reasons and to pursue new career opportunities nearer to his...
Continue Reading
Katalyze AI Elevates Innovation with New Chief AI Officer
Advancing Pharmaceutical Manufacturing with AI Leadership Katalyze AI has recently announced a pivotal move to strengthen its capabilities in the fast-evolving field of pharmaceutical manufacturing. The company has appointed Hannes Bretschneider as Chief AI Officer, signaling its commitment to advancing Agentic AI architecture. This strategic initiative aims to enhance...
Continue Reading
Iran's Strait Closure: Defense Stocks on Edge Amid Shipping Risks
Iran announced the temporary closure of the Strait of Hormuz for live-fire drills, raising eyebrows across trading desks. This isn't just a geopolitical stunt; it’s a shot across the bow at U. S. military presence in the region, occurring right as indirect nuclear talks unfold with Washington. A maneuver like this sends ripples through markets that thrive on stability,...
Continue Reading
Aphaia Pharma's Engagement in Revolutionary Obesity Forum
Aphaia Pharma's Engagement in Revolutionary Obesity Forum Aphaia Pharma, a leading clinical-stage biopharmaceutical company, is making waves in the field of treatments for obesity and related metabolic disorders. The company has announced that its Chief Scientific Officer, Dr. Steffen-Sebastian Bolz, will share insights during a panel discussion at the much-anticipated...
Continue Reading
U.S. Strives to Diminish China's Dominance in Rare Earths
Understanding the Importance of Rare Earth Elements In recent discussions, the significance of rare earth elements (REEs) has come to the forefront of international policy. These elements play a crucial role in various sectors, from technology to defense. Currently, China holds a dominant position in the production and refinement of these vital minerals, controlling...
Continue Reading